Durability of responses to the combination of SD-101 and pembrolizumab in advanced metastatic melanoma: Results of a phase Ib, multicenter study Ribas, A., Medina, T., Kummar, S., Amin, A., Drabick, J. J., Barve, M., Daniels, G., Wong, D. L., Schmidt, E. V., Leung, A. C., Janssen, R. AMER ASSOC CANCER RESEARCH. 2018

View details for DOI 10.1158/1538-7445.AM2018-CT139

View details for Web of Science ID 000468818900128